Meeting Details

The 37th Annual General Meeting (AGM) of Neogen Chemicals Limited was held on Friday, August 21, 2026, commencing at 5:00 p.m. IST and concluding at 6:31 p.m. IST. The meeting was conducted entirely through Video Conferencing (VC) / Other Audio-Visual Means (OAVM) in compliance with circulars from the Ministry of Corporate Affairs (MCA) and SEBI, and the provisions of the Companies Act, 2013.

The deemed venue of the AGM was the Registered Office of the Company. Physical attendance was dispensed with, and the appointment of a proxy was not applicable.

Attendance and Quorum

The meeting was attended by the requisite number of members through VC/OAVM, confirming a quorum was present. The following individuals were present on the panel:

  • Mr. Anurag Surana, Chairman and Non-Executive Non-Independent Director (Chaired the meeting)
  • Dr. Harin Kanani, Managing Director
  • Ms. Unnati Kanani, Company Secretary & Compliance Officer
  • Chairmen of the Audit Committee, Stakeholders Relationship Committee, CSR Committee, Nomination and Remuneration Committee, and Risk Management Committee.
  • Representatives of the Statutory Auditors and Secretarial Auditors.

Proceedings and Management Addresses

  • Ms. Unnati Kanani welcomed the attendees and outlined the procedures for the VC/OAVM meeting and e-voting.
  • Mr. Anurag Surana delivered a welcome speech to shareholders.
  • Dr. Harin Kanani, Managing Director, delivered a speech briefing shareholders on the company's financial and business performance for FY 2025-26 and its future growth plans and proposed initiatives.
  • It was confirmed that the Integrated Annual Report for FY 2025-26, containing the audited financial statements and reports, had been circulated. The Statutory and Secretarial Auditors' Reports were noted to contain no qualifications or adverse comments and were taken as read.
  • The detailed resolutions (Agenda Items 1 to 5) were also deemed read as they were provided in the AGM notice.

Shareholder Q&A Session

Shareholders who had registered as speakers asked questions on the following topics, which were addressed by Dr. Harin Kanani:

  • Revenue, profit, EBITDA, and ROCE growth expectations for the next 3 to 5 years.
  • Expected revenue percentage from new battery material products.
  • Capacity of the Dahej Replacement Plant.
  • Commissioning status of the Pakhajan Facility.
  • Non-FEOC (Foreign Entity of Concern) compliance status.
  • Pricing of battery materials.
  • Potential benefits from PLI (Production Linked Incentive) schemes for India.
  • The Joint Venture with Morita Investment Limited.
  • Reasons for a recent downgrade in the company's credit rating.
  • The annual interest burden and control measures for it.
  • The proposed fund raise through permissible modes.
  • Status of the insurance claim related to a fire incident at the Dahej SEZ Plant.
  • Remuneration of Key Managerial Personnel (KMPs).
  • R&D expenses.
  • CSR spend.
  • The company's performance in its core specialty chemical business, battery chemicals business, and CSM (Contract Synthesis and Manufacturing) business.
  • Usage of AI and its effect on the business.

Management provided satisfactory clarifications to all queries.

E-Voting Process

  • Remote e-voting was conducted by the RTA, MUFG Intime India Private Limited, from August 18, 2026, at 9:00 a.m. IST to August 20, 2026, at 5:00 p.m. IST.
  • E-voting during the AGM was available for members who had not voted remotely. This facility opened at the meeting's start (5:00 p.m.) and ended 30 minutes after the conclusion (7:01 p.m.).
  • CS Devendra V. Deshpande of DVD & Associates, Company Secretaries, Pune, was appointed as the Scrutinizer to ensure a fair and transparent voting process.
  • The consolidated results of the voting were to be declared within 2 working days of the AGM's conclusion and made available on the websites of the Company, BSE, NSE, and the RTA.

Business Conducted

The following items of business, as per the AGM notice, were placed for shareholder approval:

| Sr. No. | Description of Resolution | Type of Resolution |

| 1 | To receive, consider, and adopt the Audited Standalone and Consolidated Financial Statements for the year ended March 31, 2026, along with the Reports of the Board and Auditors. | Ordinary |

| 2 | To declare a final dividend of ₹1 per fully paid-up equity share (face value ₹10) for the financial year ended March 31, 2026. | Ordinary |

| 3 | To reappoint Dr. Harin Kanani (DIN: 05136947) as a Director who retires by rotation. | Ordinary |

| 4 | To authorize the Board to issue securities through permissible modes of fund-raising. | Special |

| 5 | To ratify the remuneration payable to the Cost Auditor. | Ordinary |

Conclusion

The meeting concluded at 6:31 p.m. with a vote of thanks from the Chair.